Effective protection induced by three different versions of the porcine S3Pvac anticysticercosis vaccine against rabbit experimental Taenia pisiformis cysticercosis

Vaccine

Volumn 30, Issue 17, 2012, Pages 2760-2767

  Betancourt, Miguel Angel ^a   De Aluja, Aline S ^a   Sciutto, Edda ^a   Hernández, Marisela ^a   Bobes, Raúl J ^a   Rosas, Gabriela ^b   Hernández, Beatriz ^c   Fragoso, Gladis ^a   Hallal Calleros, Claudia ^b   Aguilar, Liliana ^d   Flores Peréz, Iván ^b  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b UNIVERSIDAD AUTÓNOMA DEL ESTADO DE MORELOS   (Mexico)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^d INSTITUTO NACIONAL DE INVESTIGACIONES FORESTALES   (Mexico)

Author keywords

Cysticercosis; Delivery system; S3Pvac; Taenia pisiformis; Taenia solium; Vaccination

Indexed keywords

RECOMBINANT VACCINE; S3PVAC ANTICYSTICERCOSIS VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYSTICERCOSIS; DRUG EFFICACY; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; INFECTION PREVENTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROVOCATION TEST; RABBIT; TAENIA PISIFORMIS CYSTICERCOSIS;

ANIMALS; BASE SEQUENCE; CYSTICERCOSIS; CYSTICERCUS; FEMALE; INFLAMMATION; INSECT PROTEINS; LIVER; MOLECULAR SEQUENCE DATA; NADH DEHYDROGENASE; PERITONEAL CAVITY; PROTOZOAN VACCINES; RABBITS; SEQUENCE ALIGNMENT; TAENIA;

EID: 84858709568     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.02.022     Document Type: Article

References (40)

1. Sarti E., Flisser A., Schantz P.M., Gleizer M., Loya M., Plancarte A., et al. Development and evaluation of a health education intervention against Taenia solium in a rural community in Mexico. Am J Trop Med Hyg 1997, 56(2):127-132.
2. Roman G., Sotelo J., Del Brutto O., Flisser A., Dumas M., Wadia N., et al. Proposal to declare neurocysticercosis an international reportable disease. Bull World Health Organ 2000, 78(3):399-406.
3. Boa M., Mukaratirwa S., Willingham A.L., Johansen M.V. Regional action plan for combating Taenia solium cysticercosis/taeniosis in Eastern and Southern Africa. Acta Trop 2003, 87(1):183-186.
4. Eddi C., Nari A., Amanfu W. Taenia solium cisticercosis/teniosis: potential linkage with FAO activities; FAO support possibilities. Acta Trop 2003, 87(1):145-148.
5. Engels D., Urbani C., Belotto A., Meslin F., Savioli L. The control of human (neuro) cysticercosis: which way forward?. Acta Trop 2003, 87(1):177-182.
6. Pawlowski Z., Allan J., Sarti E. Control of Taenia solium taeniasis/cysticercosis: from research towards implementation. Int J Parasitol 2005, 35(11-12):1221-1232.
7. Lightowlers M.W., Waterkeyn J.G., Rothel J.S., Gauci C.G., Harrison G.B. Host-protective fragments and antibody binding epitopes of the Taenia ovis 45W recombinant antigen. Parasite Immunol 1996, 18(10):507-513.
8. Molinari J., Rodriguez D., Tato P., Soto R., Arechavaleta, Solano S. Field trial for reducing porcine Taenia solium cysticercosis in Mexico by systematic vaccination of pigs. Vet Parasitol 1997, 69(1-2):55-63.
9. Huerta M., de Aluja A.S., Fragoso G., Toledo A., Villalobos N., Hernández M., et al. Synthetic peptide vaccine against Taenia solium pig cysticercosis: successful vaccination in a controlled field trial in rural Mexico. Vaccine 2001, 20(1-2):262-266.
10. Morales J., Martínez J.J., Manoutcharian K., Hernández M., Fleury A., Gevorkian G., et al. Inexpensive anti-cysticercosis vaccine: S3Pvac expressed in heat inactivated M13 filamentous phage proves effective against naturally acquired Taenia solium porcine cysticercosis. Vaccine 2008, 26(23):2899-2905.
11. Assana E., Kyngdon C.T., Gauci C.G., Geerts S., Dorny P., De Deken R., et al. Elimination of Taenia solium transmission to pigs in a field trial of the TSOL18 vaccine in Cameroon. Int J Parasitol 2010, 40(5):515-519.
12. Rassy D., Bobes R.J., Rosas G., Anaya V.H., Brehm K., Hernandez B., et al. Characterization of S3Pvac anti-cysticercosis vaccine components: implications for the development of an anti-cestodiasis vaccine. PLoS ONE 2010, 5(6):e11287.
13. Morales J., de Aluja A.S., Martínez J.J., Hernández M., Rosas G., Villalobos N., et al. Recombinant S3Pvac-phage anticysticercosis vaccine: simultaneous protection against cysticercosis and hydatid disease in rural pigs. Vet Parasitol 2011, 176(1):53-58.
14. Olguín S. Programa de control de la teniasis-cisticercosis. Gaceta Bioméd 2010, 15:8-9.
15. Hernández M., Cabrera-Ponce J.L., Fragoso G., López-Casillas F., Guevara-García A., et al. A new highly effective antycisticercosis vaccine expressed in transgenic papaya. Vaccine 2007, 25(21):4252-4260.
16. Sciutto E., Hernández M., Díaz-Orea A., Cervantes J., Rosas-Salgado G., Morales J., et al. Towards a practical and affordable oral papaya-based vaccine: a crucial tool for taeniasis/cysticercosis control programs. Bioprocess Sciences and Technology 2011, 325-340. Nova Science Publishers, New York. Min-Tze Liong (Ed.).
17. Mason H.S., Warzecha H., Mor T., Arntzen C.J. Edible plant vaccines: applications for prophylactic and therapeutic molecular medicine. Trends Mol Med 2002, 8(7):324-329.
18. Walmsley A.M., Arntzen C.J. Plant cell factories and mucosal vaccines. Curr Opin Biotechnol 2003, 14(2):145-150.
19. Onyango-Abuje J.A., Waiyaki P.G., Gathuma J.M. Specific and shared antigenic of Taenia saginata oncospheres. Res Vet Sci 1989, 47(2):236-240.
20. Garcia-Allan C., Martínez N., Flisser A., Aluja A., Allan J.C., Craig P.S. Immunocharacterization of Taenia solium oncosphere and metacestode antigens. J Helminthol 1996, 70(4):271-280.
21. Toledo A., Larralde C., Fragoso G., Gevorkian G., Manoutcharian K., Hernández M., et al. Towards a Taenia solium cysticercosis vaccine: an epitope shared by Taenia crassiceps and Taenia solium protects mice against experimental cysticercosis. Infect Immun 1999, 67(5):2522-2530.
22. Toledo A., Fragoso G., Rosas G., Hernandez M., Gevorkian G., López-Casillas F., et al. Two epitopes shared by Taenia crassiceps and Taenia solium confer protection against murine T. crassiceps cysticercosis along with a prominent T1 response. Infect Immun 2001, 69(3):1766-1773.
23. Flatt R.E., Campbell W.W. Cysticercosis in rabbits: incidence and lesions of the naturally occurring disease in young domestic rabbits. Lab Anim Sci 1974, 24(6):914-918.
24. Craig P.S., Zumbuehl O. Immunization against experimental rabbit cysticercosis using liposome-associated antigen preparations. J Helminthol 1988, 62(1):58-62.
25. Betancourt-Alonso M.A., Orihuela A., Aguirre V., Vázquez R., Flores-Pérez F.I. Changes in behavioural and physiological parameters associated with Taenia pisiformis infection in rabbits (Oryctolagus cuniculus) that may improve early detection of sick rabbits. World Rabbit Sci 2011, 19(1):21-30.
26. Gasser R.B., Zhu X., McManus D.P. NADH dehydrogenase subunit 1 and cytochrome c oxidase subunit I sequences compared for members of the genus Taenia (Cestoda). Int J Parasitol 1999, 29(12):1965-1970.
27. Edwards G.T., Herbert I.V. Some quantitative characters used in the identification of Taenia hydatigena, T. ovis, T. pisiformis and T. multiceps adult worms, and T. multiceps metacestodes. J Helminthol 1981, 55(1):1-7.
28. Notredame C., Higgins D.G., Heringa J. T-Coffee. A novel method for fast and accurate multiple sequence alignment. J Mol Biol 2000, 302(1):205-217.
29. Altschul S.F., Gish W., Miller W., Myers E.W., Lipman D.J. Basic local alignment search tool. J Mol Biol 1990, 215:403-410.
30. Wang I.C., Ma Y.X., Kuo C.H., Fan P.C. A comparative study on egg hatching methods and oncosphere viability determination for Taenia solium eggs. Int J Parasitol 1997, 27(11):1311-1314.
31. Worley D.E. Quantitative studies on the migration and development of Taenia pisiformis larvae in laboratory rabbits. Lab Anim Sci 1974, 24(3):517-522.
32. Flatt R.E., Moses R.W. Lesions of experimental cysticercosis in domestic rabbits. Lab Anim Sci 1975, 25(2):162-167.
33. Manoutcharian K., Diaz-Orea A., Gevorkian G., Fragoso G., Acero G., González E., et al. Recombinant bacteriophage-based multiepitope vaccine against Taenia solium pig cysticercosis. Vet Immunol Immunopathol 2004, 99(1-2):11-24.
34. Rosas C., Pérez M., Castillo H., Flores F.I. Histological changes induced by medroxyprogesterone acetate on the uterus of ovariectomized rabbits. Vet Mex 2007, 38:207-215.
35. Rosas G., Fragoso G., Garate T., Hernández B., Ferrero P., Foster-Cuevas M., et al. Protective immunity against Taenia crassiceps murine cysticercosis induced by DNA vaccination with a Taenia saginata tegument antigen. Microbes Infect 2002, 4(14):1417-1426.
36. Cruz-Revilla C., Toledo A., Rosas G., Huerta M., Flores-Perez I., Peña N., et al. Effective protection against experimental Taenia solium tapeworm infection in hamsters by primo-infection and by vaccination with recombinant or synthetic heterologous antigens. J Parasitol 2006, 92(4):864-867.
37. León-Cabrera S., Cruz-Rivera M., Mendlovic F., Avila-Ramírez G., Carrero J.C., Laclette J.P., et al. Standardization of an experimental model of human taeniosis for oral vaccination. Methods 2009, 49(4):346-350.
38. Craig P.S. Circulating antigens, antibodies and immune complexes in experimental Taenia pisiformis infections of rabbits. Parasitology 1984, 89(Pt 1):121-131.
39. Gemmell M.A. Immunological responses of the mammalian host against tapeworm infections. II. Species specificity of hexacanth embryos in protecting rabbits against Taenia pisiformis. Immunology 1965, 8:270-280.
40. Cai W.M., Qiu D.C., Hatz C. Studies on ultrasonographic diagnosis of Schistosomiasis japonica in China-a review of selected Chinese studies. Acta Trop 1992, 51(1):37-43.